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The vascularization of tissue engineered products represents a key issue in regenerative
medicine which needs to be addressed before the translation of these protocols to
the bedside can be foreseen. Here we propose a multistep procedure to prepare
pre-vascularized three-dimensional (3D) cardiac bio-substitutes using dynamic cell cultures
and highly porous biocompatible gelatin scaffolds. The strategy adopted exploits the
peculiar differentiation potential of two distinct subsets of adult stem cells to obtain human
vascularized 3D cardiac tissues. In the first step of the procedure, human mesenchymal
stem cells (hMSCs) are seeded onto gelatin scaffolds to provide interconnected vessel-like
structures, while human cardiomyocyte progenitor cells (hCMPCs) are stimulated in vitro
to obtain their commitment toward the cardiac phenotype. The use of a modular bioreactor
allows the perfusion of the whole scaffold, providing superior performance in terms
of cardiac tissue maturation and cell survival. Both the cell culture on natural-derived
polymers and the continuous medium perfusion of the scaffold led to the formation of
a densely packaged proto-tissue composed of vascular-like and cardiac-like cells, which
might complete maturation process and interconnect with native tissue upon in vivo
implantation. In conclusion, the data obtained through the approach here proposed
highlight the importance to provide stem cells with complementary signals in vitro able to
resemble the complexity of cardiac microenvironment.
Keywords: cardiac tissue engineering, adult stem cells, vascularized three-dimensional (3D) scaffolds, dynamic
culture, patient-derived stem cells
INTRODUCTION
The successful regeneration of injured areas of the myocardium
by tissue-engineered constructs relies on the long time viabil-
ity and persistence of the bio-substitute in vivo, given the harsh
conditions cells in the infarcted milieu are exposed to. Previous
investigations revealed the sudden disappearance of cells admin-
istered by injection—systemically or locally—independent of cell
type. This negative outcome has been ascribed to the low reten-
tion and high mortality of cells in the hypoxic environment
characterized by an inflammatory response and the lack of local
blood supply (Gnecchi et al., 2008; Menasche, 2011). The issue of
promoting ischemic area vascularization has been lately addressed
by cardiac tissue engineers through different approaches: (i) the
administration of pro-angiogenic factors supplied by direct injec-
tion or through drug-releasing carriers (Sato et al., 2001; Chiu
and Radisic, 2010; Singh et al., 2012); (ii) the infusion of endothe-
lial progenitors (EPCs) or mature endothelial cells (ECs; Lian
et al., 2008); and (iii) the pre-vascularization of the tissue con-
structs produced in vitro before implantation (Caspi et al., 2007;
Dvir et al., 2009). Although the first two strategies are potentially
interesting in a therapeutic perspective, they rely on the in situ
generation and organization of vascular structures which depend
either on the bioavailability of beneficial molecules or on the
growth and differentiation capacity of vascular cells or their pro-
genitors (Lovett et al., 2009). The early clinical trials in which
growth factors or cells were delivered to the injured heart yielded
disappointing results in terms of improvement of cardiac func-
tion (Urbich et al., 2005; Dubois et al., 2010; Simón-Yarza et al.,
2012). The pre-vascularization of cardiac patches is also appropri-
ate for providing a capillary network to support cells in the inner
core of the implant, while biocompatible substrates are deemed
to contribute to the improvement of retention and engraftment
of the transplanted cardiac tissue (Terrovitis et al., 2010; Segers
and Lee, 2011). The advantage of the pre-vascularization of thick
muscle constructs was underlined by the demonstration that co-
cultures including skeletal myoblasts, endothelial cells (or their
progenitors) and embryonic fibroblasts on biocompatible porous
scaffolds can enhance the overall survival and functionality of
the constructs in vivo (Levenberg et al., 2005). Moreover, the
adoption of scaffolds displaying an interconnected porosity itself
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could foster host vascular cell recruitment, with the possibil-
ity of vessels branching throughout the core of the construct.
Alternatively, scaffoldless thick cardiac constructs were provided
with a vascular bed (Sekine et al., 2013), or with microchan-
nels (Sakaguchi et al., 2013) to favor vessel ingrowth, although
biocompatible supports improve the handling of the grafts and
can provide cells with appropriate bio-mechanical signals to bet-
ter induce tissue regeneration and repair. In this context, the
use of porous gelatin scaffolds represents a suitable tool for car-
diac tissue engineering application (Sakai et al., 2001; Akhyari
et al., 2002). In fact, gelatin is a cheap polymer derived from
collagen denaturation and hydrolysis, and, due to its natural
origin, it displays excellent cell adhesion property (Wu et al.,
2011). It also features high biocompatibility, low immunogenic-
ity, and biodegradability (Xing et al., 2014). In addition, gelatin
sponges have been proven effective in inducing angiogenesis
(Dreesmann et al., 2007) and their porous structure can favor
the vascularization of the construct by supporting the diffusion
of cells and nutrients within its core area. Its mechanical proper-
ties can be easily adjusted to match those encountered in living
tissues.
The use of autologous stem cells has been proposed for var-
ious cell therapy applications as a mean to avoid the immune
rejection issues raised by allogeneic or xenogeneic derivatives
and the ethical concerns due to the use of embryonic material.
Human bone marrow-derived mesenchymal stem cells (hMSCs)
are an excellent candidate for regenerative medicine applications
due to their autologous origin, their immunomodulatory prop-
erties and relative safety in clinical practice (Lalu et al., 2012).
The in vitro multilineage differentiation potential of mesodermal
progenitors has been proven in a number of studies (Pittenger
et al., 1999; Muraglia et al., 2000) and their ability to express
endothelial markers upon growth factor stimulation (Oswald
et al., 2004; Jazayeri et al., 2008; Portalska et al., 2012) and
response to bio-mechanical stimulation (stretching, shear stress,
substrate mechanical properties tuning; Lozito et al., 2009; Bai
et al., 2010) has been shown. More importantly, the benefits of
MSC-based therapy have mainly been ascribed to their ability to
generate endothelial cells and exert pro-angiogenic and cardio-
protective effects by paracrine mechanisms rather than to direct
the generation of new contractile cells (Gnecchi et al., 2008;Meyer
et al., 2009; Wöhrle et al., 2010; Loffredo et al., 2011).
Among the adult stem cell subsets so far proposed for cardiac
muscle repair, resident cardiac stem/progenitor cells (CSCs or
CPCs) were shown to retain the ability to differentiate into all the
cardiac tissue cell types (Beltrami et al., 2003; Forte et al., 2011)
and favor cardiac healing by direct production of contractile cells
in vivo (Smits et al., 2009a,b).
By taking advantage of the peculiar differentiation potential of
hMSCs and human cardiomyocyte progenitor cells (hCMPCs),
in the present investigation we propose a multistep procedure to
obtain human pre-vascularized three-dimensional (3D) cardiac
bio-substitutes based on highly porous gelatin scaffolds display-
ing the stiffness of cardiac tissue. Given the thickness and the
dimensions of the bio-construct, a modular dynamic culture sys-
tem has been used to guarantee scaffold perfusion and promote
cell colonization of the inner layers.
Although being here tested exclusively in vitro, the present
method allows for the formation of a 3D cardiac construct based
on a physiological environment given by the gelatin scaffold and
featuring the use of autologous stem cells with unique potential.
MATERIALS AND METHODS
PREPARATION OF POROUS GELATIN SCAFFOLDS
All materials used (unless specified) were purchased from Sigma-
Aldrich (Italy). A 5% w/v gelatin solution was prepared by dis-
solving gelatin (Type A, G1890, 300 bloom strength) in deionized
water. Porous gelatin scaffolds were prepared with a multi-step
procedure. The solution was stirred for 1 h at 50◦C, allowing
complete dissolution, then casted in cylindrical shaped mold
and physically gelled at room temperature. Samples were kept
at 4◦C for 1 h, and then at −20◦C overnight. Gelatin samples
were then freeze-dried (−50◦C, 150 mBar) to obtain a porous
structure as described elsewhere (Lien et al., 2009). Samples were
swollen in deionized water and then cross-linked by immer-
sion in a 10mM glutaraldehyde (GTA) solution in 40% v/v
ethanol/deionized water. The crosslinking reaction was controlled
by keeping the glutaraldehyde/gelatin ratio (defined asmolar con-
centration of GTA versus gelatin weight) constant. The scaffolds
were immersed in GTA solution at 4◦C for 48 h, until the cross-
linking reaction occurred. Therefore, the samples were immersed
in 0.1M glycine solution in deionized water for 2 h at room
temperature in order to stop any further cross-linking reaction
(and remove any excess of GTA). Phosphate buffered solution
(PBS) was sequentially used to rinse samples. Samples were kept
at −20◦C overnight, and finally freeze-dried (−50◦C, 150 mBar)
until all water content was removed. Samples were then stored at
room temperature and sterilized with gas plasma before using.
SCAFFOLD MECHANO-ARCHITECTURAL PROPERTIES: SWELLING,
POROSITY, AND STIFFNESS
Water absorption capability, porosity and stiffness of the porous
gelatin scaffolds were evaluated using the procedure described
elsewhere (Spinelli et al., 2012). Swelling ratio (Q) was cal-
culated from the ratio of the weight of a dry (W0) and a
completely swollen (Weq) sample (Brannon-Peppas and Peppas,
1990) returning the amount of adsorbed water. For the mea-
surements, cryogel were swollen in deionized water at room
temperature and weighted (Wi) at different time points until
a swelling equilibrium was reached. A precision microbalance
(AE240, Mettler, Italy) was used: in case of wet samples, blotting
paper was used to remove the water in excess. Porosity was indi-
rectly evaluated by the imbibition method (Mwangi and Ofner,
2004; Martucci et al., 2006), while pore size was directly measured
by processing both Scanning Electron Microscopy (SEM) and
optical microscopy acquisition of sample sections with ImageJ
(Abramoff et al., 2004). Sample stiffness was measured by com-
pressive mechanical tests. Prior to the tests, samples were com-
pletely swollen in deionized water, compressive tests were then
performed using a Zwick-Roell Z005 Instron twin column-testing
machine (Zwick Testing Machines Ltd., UK). Samples were com-
pressed up to 5% of their initial length using a 0.01mm·s−1 strain
rate; tests were performed with the samples partially immersed in
water to preserve their hydration. Data were then post-processed
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and stress-strain curves were obtained. Samples stiffness was eval-
uated within 1% strain (first linear zone) of the stress-strain
curve.
BIOREACTOR WORKING CONDITIONS
A computational fluid-dynamic (CFD) analysis of the modular
chamber bioreactor with a porous scaffold was performed, assess-
ing the perfusion and oxygenation of themillimeter sized scaffold.
The analysis was performed using Brinkman and Incompressible
Navier-Stokes equations were combined with reaction and dif-
fusion equations using Comsol Multiphysics (COMSOL AB,
Stockholm, Sweden). The systemwas thenmodeled with a porous
domain representing the scaffold (porous section of 2 × 12mm
in size, with permeability of 1.68 × 10−10 m2 and 90% porosity)
placed on the bottom of the bioreactor perfusion chamber, which
is represented by a fluid domain. A preliminary analysis was per-
formed in order to verify scaffold oxygenation as function of
bioreactor flow rate (Supplementary Figure 1A). Chosen an inner
flow rate to a value of 200μL/min, fluid flow inside the perfusion
chamber and scaffold’s perfusion was analyzed (Supplementary
Figure 1B).
CELL CULTURE
hMSCs were purchased from Lonza and cultured in MSCGM™
BulletKit™ (hMSC basal medium, Lonza Japan Ltd, Tokyo,
Japan). The cells were expanded to the desired number and
used between passages 3 and 7. For the endothelial differ-
entiation in 2D conditions, hMSCs were seeded onto tissue
culture polystyrene plates (TCPS) and cultured for 7 days
in endothelial differentiation medium [(EDM: hMSC basal
medium supplemented with 50 ng/ml VEGF165 (R&D sys-
tems)]. hCMPCs were isolated from healthy donor atrial biop-
sies, cultured in basal medium (M199/EGM-2 (Lonza) (3:1)
10% FBS (Equitech-Bio Inc., Kerrville, Texas, USA), 1% MEM
nonessential amino acids (from 50× stock; Life Technologies
Gaithersburg, Maryland, USA) and 2% penicillin/streptomycin
(from 50× stock; Invitrogen, Carlsbad, California, USA)
and differentiated in cardiac differentiation medium (CDM:
IMDM/Hams F12 (1:1, Life Technologies) with L-glutamine (Life
Technologies), 2% horse serum (Life Tchnologies), nonessen-
tial amino acids, insulin–transferrin–selenium (Invitrogen),
penicillin/streptomycin) as previously described (Smits et al.,
2009a,b). Briefly, minced auricle were digested in collagenase A
(1mg/ml) for 2 h at 37◦C while stirring. Afterwards, the solu-
tion was filtered through 40-μm cell strainer and centrifuged at
300 g for 5min at RT. Then, the pellet was resuspended in cold
buffer containing EDTA (2mM) and 2% FBS and filtered through
40-μm cell strainer. The filtered cell population was subjected
to magnetic cell sorting (Miltenyi Biotec, Sunnyvale, CA, USA)
using Sca-1-coupled beads, following the manufacturer’s proto-
col, in order to isolate Sca-1-like+ progenitor cells. The cells were
cultured on 0.1% gelatin- (Sigma-Aldrich, St Louis, Missouri,
USA) coated plates in basal medium. For cardiac differentiation,
cells were grown in differentiation medium supplemented with
5μM 5-azacytidine (Wako Pure Chemical Industries, Ltd, Osaka,
Japan) for 72 h. After induction, the medium was replaced with
differentiation medium supplemented with 10−4 M ascorbic acid
(Wako) and TGF-β1 (1 ng/ml, PeproTech, Rocky Hill, NJ, USA)
and changed every 3 days for up to 3 weeks. Human umbilical vein
endothelial cells (HUVEC) were purchased from Lonza, grown in
EGM-2 bullet kit media and used between passage 2 and 4. The
media were replenished every other day.
GENERATION OF TNT-GFP hCMPCs
The pGreenZeo lentiviral expression vector carrying the full-
length copGFP gene under the control of cardiac Troponin T
type 2 (TNNT2) promoter was purchased from SBI (System
Biosciences Inc. Mountain View, CA, USA) and delivered into
mammalian cells according to the manufacturer’s instructions.
Briefly, hCMPCs were transduced at an approximate MOI of 20
and incubated at 37◦C overnight. The following day, half of the
culture medium was replaced with fresh medium and 48 h after
the transduction, the medium was discarded and fresh medium
added. The cells (hereafter referred as cTNT-GFP hCMPCs) were
cultured on TCPS or gelatin scaffolds in the presence of basal
medium or CDM.
CELL SEEDING AND 3D DISTRIBUTION IN GELATIN SCAFFOLDS
Prior to cell seeding, gelatin scaffolds were swollen in cell cul-
ture medium in Ultra-low Attachment 24-well plates (Corning®
Incorporated) for 24 h. The cells (2.0 × 105) were directly seeded
on top of each scaffold in a small volume (100μl) of appropriate
medium and allowed to adhere for 60min before adding the rest
of medium. Then, the scaffolds were placed in the incubator for
12 h and transferred in another low-adhesion well. Cardiac TNT-
GFP hCMPCs were cultured into scaffolds for 7 days in complete
hCMPCs basal medium or CDM, while hMSCs-seeded scaffolds
were cultured for 4 days in a mixture of Matrigel™/hMSCs basal
medium (1:10) with or without VEGF (50 ng/mL) before being
processed or co-cultured with pre-conditioned cardiac progeni-
tors. The formation of vascular-like structures on gelatin scaffolds
was followed by labeling hMSCs with the membrane-permeable
live-cell labeling dye Calcein AM (Invitrogen) after 4 days of cul-
ture in EDM. Briefly, Calcein AM was added to hMSC-seeded
scaffolds at a final concentration of 2μM for 30min at 37◦C
and 5% CO2 in the dark. Five scaffolds have been used for
any single experiment. The experiments have been performed
independently three times.
DYNAMIC CULTURE
A commercial modular chamber bioreactor (Quasi-Vivo®,
QV500, Kirkstall, United Kingdom) was used to perfuse the scaf-
folds. The main feature of this system is the ability to apply high
flow rates and provide high nutrient turnover to cells without
imposing high shear stress or turbulent flow (Mazzei et al., 2010).
Pre-seeded scaffolds were gently transferred into the bioreactor
chamber, and then the chamber was filled with cell culture media
prior to perfusion. Two Quasi-Vivo® chambers and one mix-
ing chamber (growth medium reservoir) were then connected in
series to a peristaltic pump (High Performance Perista BIO-MINI
PUMP, ATTO) giving a final volume of cell culturemedia of about
21mL. The use of the mixing chamber guarantees medium oxy-
genation (Figure 1). To establish the optimal flow rate, the gelatin
porous scaffold was included in the fluid-dynamic and oxygen
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FIGURE 1 | QuasiVivo Bioreactor (QV500). The bioreactor is composed of
a peristaltic pump keeping a constant medium flow rate (200μl/min) from
the growth medium reservoir to two culture chambers connected in series,
thus allowing scaffold inner layer perfusion.
transport model previously described (Mazzei et al., 2010), giving
consistent results (Supplementary Figure 1). Cardiac TNT-GFP
hCMPCs grown for 7 days onto gelatin scaffolds in the bioreac-
tor were used to study the effect of dynamic culture conditions
on cell growth, differentiation potential and gene expression
profile. The medium was replenished every third day. For the
generation of vascularized cardiac grafts, scaffolds were soaked
for 12 h in diluted Matrigel™ (1:10 in hMSC basal medium)
and switched to a new low-adhesion plate in EDM. The pre-
conditioned scaffold was loaded with 2.0 × 105 hMSCs and kept
for 4 days in the incubator at 37◦C, 5% CO2. After a 2 week
pre-conditioning passage in CDM on TCPS, 2.0 × 105 cTNT-
GFP hCMPCs were seeded onto the vascularized scaffold and
allowed to attach for 24 h. Thence, the cell-loaded scaffolds were
carefully moved to Quasi-vivo bioreactor chambers and perfused
with CDM at 200μl/min (the rate suggested by the computa-
tional model) for 7 days. Cells grown on TCPS and 3D scaffolds
under static conditions were used as controls. Five scaffolds have
been used for any single experiment. The experiments have been
performed independently three times.
REAL-TIME QUANTITATIVE PCR ANALYSIS
Total RNA was extracted by TRIZOL® Reagent according to
the manufacturer’s instructions (Invitrogen). One microgram of
RNA for each sample, measured by NanoDrop 2000 (Thermo
Scientific) and assessed on ReadyAgarose Precast Gel (Bio-Rad),
was retro-transcribed using RT2 First Strand Kit including DNAse
treatment to remove genomic DNA (SA Biosciences Corp.,
USA). The resulting cDNA was diluted 1:10 in DNase/RNase-
free water and the expression profile of genes involved in
different pathways analyzed by the following RT2 Profiler™
PCR Arrays (SA Biosciences Corp.): (i) RT2 Profiler™ PCR
Array Human Angiogenesis (PAHS-024Z); (ii) RT2 Profiler™
PCR Array Human Extracellular Matrix & Adhesion Molecules
(PAHS-013); (iii) qBiomarker iPSC PCR Array Cardiomyocytes
differentiation (iPHS102); (for a comprehensive list of genes
included in these arrays please refer to Supplementary Table
1). Real-time PCR was performed on ABI 7500 Real-Time PCR
System (AB Applied Biosystems, Foster City, CA) using RT2 SYBR
Green/ROX qPCRMasterMix (SA Biosciences Corp.) and the fol-
lowing cycling parameters: 1 cycle at 95◦C for 10min; 40 cycles
at 95◦C for 15 s, and 60◦C for 1min. Data was analyzed by the
Ct method with the PCR Array Data Analysis Web Portal
(http://www.SABiosciences.com/pcrarraydataanalysis.php). The
graphs show the mean values of obtained fold changes by
analyzing independently two samples per each experimental
condition.
STATISTICAL ANALYSIS
Data are represented as mean ± SD. Student’s T-test was used to
analyze the data. Comparisons between different conditions were
considered statistically significant for P < 0.05.
For a more extensive description of the Materials andMethods
used, please refer to Supplementary Information.
RESULTS
MODELING THE MULTI-DIMENSIONAL IN VITRO SYSTEM THROUGH
GELATIN SCAFFOLDS DISPLAYING CARDIAC-LIKE MECHANICAL
PROPERTIES
Three dimensional gelatin scaffolds were characterized for their
structure, water affinity, and stiffness. The analysis of the sections
showed a distinctive bimodal pore size distribution. Although
the average pore diameter ranged between 50–200μm (with
a few having a maximum size of 500μm), the smaller pores
were approximately double the size of the bigger pores (diam-
eters of 61.62 ± 24.01 and 140.38 ± 19.51μm, respectively;
Figure 2A). Swelling tests were performed to assess the scaffold
capacity to retain water. The scaffolds were monitored over 24 h
of immersion in cell culture media, showing a complete rehy-
dration after 8 h with a swelling ratio of about 10.92 ± 0.32
(Figure 2B). These data were also used to measure scaffold poros-
ity, which was found to be approximately 90% (also confirmed
in Spinelli et al., 2012). Finally, compressive mechanical tests
were also performed on swollen samples (after 24 h in cell cul-
ture media), and on samples kept immersed in cell culture media
and in the incubator for 1 week. Scaffold stiffness (evaluated
within the first linear region of stress-strain plot, Figure 2C) was
10.5 ± 1.4 kPa, which was stable in time. After scaffold charac-
terization and assessment of mechano-architectural properties,
attention was dedicated to define the most suitable working con-
ditions of the bioreactors to guarantee a homogeneous scaffold
oxygenation in the bioreactor. Specifically, literature values of
hypoxic limits (1%) (Cipolleschi et al., 1993) and oxygen con-
sumption of stem cells (Km = 0.001mM, Vmax = 1 pm/min/104
cells) (Varum et al., 2011) were used to estimate the minimum
oxygen concentration at the base of the scaffold as a function of
flow rate and cell density, while the Wang and Tarbell approxi-
mation was used to calculate the shear stress at the pore walls.
Results obtained from the computational models (reported in
Supplementary Information) evidenced that—by using a flow
rate of 200μL/min—an oxygen concentration of 0.15mM at the
base of the scaffold (14%) and a shear stress of 1.10−6 Pa in
the pores are obtained (Wang and Tarbell, 1995; Boschetti et al.,
2006). The use of lower flow rates in the bioreactor may com-
promise oxygen supply rates to cells, especially as they proliferate,
while higher flow rates may cause shear-related damage (Mazzei
et al., 2010). Bioreactor parameters were set according to these
results for all the following experiments.
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FIGURE 2 | The porous gelatin scaffold. Three-dimensional rendering
of scaffold, brightfield images of scaffold section and pore dimension
analysis (A). Modifications of swelling ratio of scaffold over 24 h in
cell culture media (B). Stress-strain plot of gelatin samples (C)
obtained after 24 h and 1 week in culture medium (37◦C, 5%
CO2). ∗P < 0.05.
3D CULTURE INDUCES A GENERAL REMODELING IN THE EXPRESSION
OF GENES INVOLVED IN CELL-MATRIX INTERACTION
Establishing a physiologically relevant system requires the devel-
opment of 3D culture conditions resembling the in vivomicroen-
vironment (Pampaloni et al., 2007). As reported above, the
scaffolds here used were designed to have mechanical properties
similar to those of cardiac tissue (Engler et al., 2007). Preliminary
experiments demonstrated that culturing human hCMPCs on 3D
gelatin scaffolds for 7 days induced a clear upregulation in the
expression of genes (fold change ≥2, as compared to cells grown
on TCPS) coding for proteins involved in cell-matrix remod-
eling (collagens (COL), laminins (LAMA), metalloproteinases
(MMP) and their inhibitors (TIMP) and cell-cell adhesion (inte-
grins) (Figure 3, for a complete list of the genes analyzed see
Supplementary Table 1) and testified the actual activity of the cells
in remodeling the scaffold.
3D POROUS GELATIN SCAFFOLDS REPRESENT A PERMISSIVE
ENVIRONMENT FOR STEM CELL CARDIAC AND ENDOTHELIAL
COMMITMENT
The hCMPC reporter cell line (cTNT-GFP hCMPCs) was driven
toward a cardiac phenotype in both 2D (Supplementary Figure 2)
and 3D conditions, when stimulated with CDM (Figure 4A). Cell
commitment was confirmed by the up-regulation of a number
of cardiac-specific genes like actinin alpha 2 (ACTN2), adreno-
ceptor beta 1 (ADRB1), desmin (DES), cardiac troponin T type
2 (TNNT2), cardiac troponin I type 1 (TNNI1), myosin light
chain (MYL) 2, 3, 7, myosin heavy chain b (MYH7) in car-
diac progenitors stimulated on the scaffold as compared to their
respective control (3D culture in basal medium). Moreover, when
compared to cells cultured in CDM on TCPS, hCMPCs grown
onto gelatin scaffolds encountered the up-regulation of few car-
diac genes, confirming a superior performance of 3D vs. 2D
culture conditions (Figure 4B, for a complete list of the genes ana-
lyzed see Supplementary Table 1). On the other hand, the ability
of hMSCs to acquire an endothelial phenotype (Supplementary
Figure 3) was exploited to obtain endothelial cells from hMSCs
under 3D culture conditions. The scaffolds were treated with a
mixture of EDM and Matrigel™ for 24 h. SEM analysis showed
that the interconnected porosity of the scaffold was not modi-
fied by Matrigel™ treatment (highlighted by yellow dotted line
in Figure 4C) and that the successful adhesion of human cells
was achieved (Figure 4C, right). Consequently, hMSCs grown on
3D gelatin scaffolds in EDM displayed the up-regulation of a
wide range of angiogenic markers as compared to cells cultured
on scaffolds in basal medium (Figure 4D, for a complete list of
the genes analyzed see Supplementary Table 1). Confocal anal-
ysis of 3D scaffolds after 4 day hMSC culture demonstrated the
establishment that cells loaded with Calcein AM or expressing
endothelial marker VCAM-1 colonized the whole scaffold, while
aligning around the pores (Figure 4E).
DYNAMIC CULTURE CONDITIONS PROVIDE SUPERIOR PERFORMANCE
IN TERMS OF CARDIAC COMMITTMENT OF hCMPCs
The use of dynamic culture conditions using a bioreactor is
thought to increase cell survival within a 3D structure by favor-
ing inner core perfusion and catabolite removal (Cimetta et al.,
2007; Burdick and Vunjak-Novakovic, 2009; Vozzi et al., 2011).
Indeed, a slight although not significant increase in DNA con-
tent, indicative of cell proliferation, could be noticed 7 days after
3D cell culture in the bioreactor, as compared to static condi-
tions (Figure 5A). Given the ability of human cardiac progenitor
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FIGURE 3 | Three-dimensional (3D) stem cell culture induces a significant
remodeling in the expression of genes involved in cell adhesion and
ECM deposition. Human cardiac progenitor cells (hCMPCs) were grown for
1 week on 3D gelatin scaffolds and the expression of 73 genes involved in
cell-matrix interaction resulted upregulated, as evidenced by real time PCR
(for a complete list of genes analyzed please refer to Supplementary Table1).
cells to proceed to cardiac maturation on 3D gelatin scaffolds,
their capacity to activate the cardiac program when exposed to
dynamic conditions in amodular bioreactor was assessed. For this
experiment, cTNT-GFP hCMPCs were pre-committed in CDM
for 2 weeks on TCPS. Afterwards, an aliquot of this cell popula-
tion was seeded onto scaffolds and further stimulated for 1 week
under static or dynamic conditions. The data confirmed that the
commitment of cTNT-GFP hCMPCs could be achieved by CDM
in dynamic conditions (Figure 5B) and that a minor although
significant spontaneous commitment of hCMPCs was induced
by 3D culture conditions per se, as also described in static cul-
ture (white columns). Although the dynamic culture conditions
did not significantly modify the percentage of GFP-positive cells
with respect to the static protocol, real time PCR array analysis
demonstrated that dynamic stimulation—when combined with
differentiation medium—could lead to the up-regulation of few
cardiac-specific genes (Figure 5C, for a complete list of the genes
analyzed see Supplementary Table 1).
GENERATION OF 3D PRE-VASCULARIZED CARDIAC CONSTRUCTS BY
DYNAMIC CULTURE AND POROUS SCAFFOLDS
Given the positive effect of dynamic culture conditions on car-
diac gene activation, we sought to obtain vascularized cardiac
3D tissues by co-culturing hMSCs-derived vascular cells and
pre-differentiated hCMPCs in the bioreactor system for 7 days,
as described in Figure 6A. Gelatin sponges were first seeded
with hMSCs under endothelial differentiation conditions. In the
meantime, cTNT-GFP hCMPCs seeded on TCPS were challenged
with CDM for 2 weeks, seeded onto hMSCs-loaded scaffolds
and allowed to adhere for 24 h before being exposed to contin-
uous medium flow. The analysis of the co-cultured constructs
after 1 week testified massive scaffold colonization by the cells
(Figure 6B). The scaffold thickness was not significantly modified
by medium perfusion (data not shown) that affected, instead, cell
migration inside the scaffold. In fact, the side of the colonized
scaffolds directly exposed to flow showed a more uniform and
extensive distribution of vascular-like cells (in red) and hCMPC-
derived cardiomyocytes (green) inside the scaffold, while the
cells were mostly distributed on the scaffold surface in the static
control (Figure 6C). The expression of VCAM-1 and CD144
endothelial markers confirmed the presence of endothelial-like
cells, while GFP expression testified the persistence of a number of
cardiac-like cells within the bio-construct (Figure 6D). Sections
from the perfusion group showed VCAM-1-positive cells aligned
forming tube-like structures around the pores and contacting
GFP-positive cells (Figure 6E). The extensive cell distribution
within the scaffold accounted for the formation of a densely
packed multicellular tissue derived from the two different stem
cell types used (Figure 6F).
DISCUSSION
Rebuilding functional portions of the myocardium requires the
generation of bio-substitutes that best recapitulate the struc-
ture and function of the healthy myocardium, thus providing
new cardiomyocytes with a functional vascular network, which
may prevent or reduce pathological decline and improve car-
diac function after injury (Simons and Ware, 2003; Kang et al.,
2013). Exploiting cell sheet technology, our group and others suc-
cessfully achieved the preparation of 3D cardiac tissues in the
absence of scaffolds by different cell types having a cardiac signif-
icance (Haraguchi et al., 2006; Forte et al., 2011; Matsuura et al.,
2012; Sekine et al., 2013). Nonetheless, the scaling up of solid
engineered tissues to obtain a critical size substitute with thera-
peutical relevance is limited by the diffusion of oxygen, nutrients
and waste products to and from the inner portion of the con-
struct, impairing the survival of the newly formed tissue. In this
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FIGURE 4 | Three-dimensional (3D) gelatin scaffolds support
multilineage stem cell commitment. After 2 weeks of cardiac
pre-commitment on TCPS, human cardiac progenitors (hCMPCs), seeded on
3D gelatin scaffolds and stimulated with cardiogenic differentiation medium
(CDM) for further 1 week, up-regulate some cardiac-specific genes, as
compared to 3D culture in basal medium (A). 3D differentiation conditions
show a higher performance (B) as compared to tissue culture polystyrene
(TCPS). The interconnected porosity of the scaffold (as outlined by yellow
dashed line and asterisks) is not modified by Matrigel™ treatment and can
(Continued)
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FIGURE 4 | Continued
accommodate human cells (C). Human mesenchymal stem cells (hMSCs) are
differentiated to endothelial cells on 3D gelatin scaffolds when stimulated
with endothelial differentiation medium (EDM) and low concentration of
Matrigel™, as demonstrated by the upregulation of several vascular genes as
analyzed by real time PCR (D). Calcein AM staining shows the network of
living cells spreading throughout the scaffold (E, upper panels). Scaffold (S)
pores are covered by lining cells expressing VCAM-1 as highlighted by white
arrowheads (E, lower panel). A magnification of a cord-like structure aligned
along a pore is visible on the right; scale bar: 100μm.
FIGURE 5 | Dynamic culture conditions induce a superior cardiac
commitment in human cardiac progenitors (hCMPCs). Dynamic culture
conditions provide a higher, although not significant, increase in scaffold cell
colonization as compared to static conditions (A). Percentage of
differentiated cTNT-GFP CMPCs stimulated with cardiogenic differentiation
medium (CDM) and cultured on TCPS and scaffolds, under dynamic, or
static conditions, as evidenced by FACS analysis (B) (∗, ∗∗, ∗∗∗P < 0.05
between hCMPC basal medium and CDM). Importantly, a significant
commitment can be induced, equivalently, by 3D culture itself in both static
and dynamic conditions compared to TCPS (+P < 0.05 between TCPS and
3D scaffolds). Nonetheless, quantitative PCR analysis demonstrates the
up-regulation of few cardiac-specific genes in hCMPCs (C) cultured in
dynamic conditions, as compared to its static control (for a complete list of
genes analyzed please refer to Supplementary Table 1; among the genes
analyzed, those not showing a consistent and significant difference in the
expression as compared to their respective controls, are not shown).
context, the use of porous scaffolds to generate in vitro artifi-
cial bio-substitutes gives the opportunity to choose the shape
and the size of the graft, while second-generation scaffolds are
currently proposed as active templates which can be removed
in a timely fashion compatible with tissue growth and exert an
instructive role in the formation of the new tissue (Forte et al.,
2013; Pagliari et al., 2013). In the present study, we propose
a multistep procedure to prepare adult stem cell-derived pre-
vascularized thick cardiac patches by using 3D porous gelatin
scaffolds and dynamic culture conditions. The procedure here
adopted is based on the peculiar differentiation potential of two
different autologous adult cell subsets, mesenchymal, and car-
diac resident stem cells. Human MSCs can be routinely obtained
from patient bone marrow and display a minimal, if any, abil-
ity to give raise to cardiomyocytes (Gnecchi et al., 2005; Loffredo
et al., 2011), while they are supposed to retain an intrinsic vascular
potential (Oswald et al., 2004). In the present investigation,
hMSCs were efficiently driven to acquire an endothelial pheno-
type by means of EDM in 3D culture conditions. In particular,
when grown on 3D porous gelatin scaffold, hMSCs showed a
robust vascular commitment as confirmed by the up-regulation
of 73 genes involved in angiogenesis. Among these, angiopoietin
1 (ANGPT1), which has been shown to promote blood vessel
maturation by regulating endothelial cell survival and the recruit-
ment of mural cells (Thomas and Augustin, 2009), encountered
a 20-fold increase, thus suggesting stability of the newly formed
vascular network. At the same time, CPCs can be extracted from
patient atrial biopsies and are known to possess the potential to
generate new cardiomyocytes in vitro and in vivo (Beltrami et al.,
2003; Goumans et al., 2007) making them an effective and safe
cardiogenic cell type (Bolli et al., 2011; Makkar et al., 2012). In
the present investigation, we explored the possibility to generate
a 3D cardiac tissue in vitro by pre-committed hCMPCs. Although
most of the attempts to regenerate damaged myocardium have
used undifferentiated cells, concerns have been raised due to
the poor differentiation capability of adult progenitors in vivo,
together with the potential of pluripotent stem cells to give birth
to undesired phenotypes. Recently, it has been suggested that the
transplantation of pre-committed cells could improve the clinical
outcome in cardiac patients (Heng et al., 2004; Mehta and Shim,
2013). For this reason, stem/progenitor cells were appropriately
stimulated to undergo tissue specific pre-commitment before
being used for all co-culture experiments. However, given that
the mechanical properties of the gelatin scaffolds used here are
similar to those of cardiac tissue, a spontaneous commitment of
cardiac progenitor cells could be obtained through 3D culture per
se, as demonstrated by the increased percentage of GFP-positive
cells and similarly to what we and others previously demonstrated
(Engler et al., 2006; Pagliari et al., 2011; Gaetani et al., 2012;
Mosqueira et al., 2014). However, despite the fact that the gene
expression profile analysis confirmed a moderate commitment
of hCMPCs induced by the scaffold itself, biological factors were
needed to improve this effect. In particular, when cells seeded on
the scaffold were stimulated with CDM, we observed an increased
expression of cardiac troponin genes (TNNT2, 3) along with the
up-regulation of ryanodine receptor 2 (RYR2, involved in muscle
excitation-contraction coupling, Bround et al., 2012) and natri-
uretic peptide precursor A (NPPA) genes. These data suggest that
the combination of 3D porous gelatin and CDM represents a suit-
able combination to provide cells with biological and mechanical
signals synergistically supporting the commitment of hCMCPs
at a later stage. Nonetheless, neither complete sarcomeric struc-
tures nor any beating activity could be noticed in prompted cells.
This evidence suggested that the system implemented represents
a good tool to induce an efficient cardiac commitment and study
the behavior of late cardiac progenitors, but this also implicates
that more complex devices providing stretching and/or electrical
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FIGURE 6 | Generation of a vascularized 3D cardiac construct by adult
stem cells grown in dynamic conditions onto gelatin porous scaffolds.
Schematic illustration of the protocol used to produce vascularized 3D cardiac
construct (A). Gelatin porous sponges were dipped in diluted Matrigel™ and
then switched to endothelial differentiation medium (EDM). Therefore,
hMSCs were allowed to colonize the scaffold and differentiate toward the
endothelial phenotype for 4 days. Cardiac TNT-GFP progenitor cells were
pre-committed for 2 weeks with cardiac differentiation medium (CDM) on
TCPS, and then cultured on vascularized scaffold for further 7 days in CDM
(Continued)
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FIGURE 6 | Continued
and in a perfusive modular bioreactor. Human cells colonize the scaffold inner
layers as shown by nuclei staining at different depths (B). Side view of
cellularized scaffolds cultured under static or dynamic conditions (C); infiltration
of GFP- (cardiomyocyte-like cells, green) and VCAM-1-positive cells
(endothelial-like cells, red) into scaffold is improved by dynamic culture.
Immunohistochemistry analysis of the colonized scaffolds shows the massive
infiltration of VCAM-1, CD144 cells in the core of the construct. Higher
magnification images (D) shows the VCAM-1-positive cells aligned in tube-like
structures around the pores and contacting GFP-positive cells (E,F). S, scaffold.
stimulation are probably necessary to deliver more specific stim-
uli and improve the outcome in terms of cardiac differentiation.
The activation of genes involved in matrix remodeling observed
in 3D testified the ability of cells to actively interact with the
natural support they grow on. In fact, while the up-regulation
of Matrix metalloproteinase (MMP) genes and their regulators,
tissue inhibitors of metalloproteinase (TIMP), is predictive of
gelatin remodeling and breakdown, the activation of genes encod-
ing for different collagens and laminins suggest the concomitant
substitution of the artificial matrix with neo-formed tissue.
Bioreactors have been widely proposed to intensify oxygen
and nutrient transport and increase the viability and function of
thick cardiovascular tissue-engineered substitutes (Zimmermann
et al., 2006; Cimetta et al., 2007; Burdick and Vunjak-Novakovic,
2009). In our experimental setting, dynamic culture conditions
positively affected cardiac commitment, leading to a significant
increase in GFP-expressing cells as compared to TCPS and inde-
pendently of biological stimulation. Since the increase in GFP was
not significantly different from that observed under 3D static cul-
ture conditions, it might be concluded that providing cells with
continuous medium flow does not positively affect on cardiac
progenitor differentiation potential on the scaffold. Nevertheless,
the expression of genes recognized to be essential for the for-
mation or regulation of the contractile apparatus was positively
influenced when dynamic flow was applied to cells grown in a 3D
environment. Hence, the use of a modular bioreactor providing
continuous media turnover to the scaffold resulted in a superior
performance in terms of cardiac gene activation. In the light of
these promising results, we also expected that direct perfusion
of cells could promote the formation of a vascularized cardiac
patch. In line with previous descriptions (Maidhof et al., 2012),
we observed more uniform and dense spatial cell distribution
in the scaffold, with cells migrating toward the substrate inner
core under dynamic conditions. Thus we established a method
for sequential cell seeding: gelatin scaffolds were colonized with
hMSCs and maintained in static conditions for 4 days in order to
favor the endothelialization of the substrate, then scaffolds were
loaded with pre-committed GFP-positive cardiac progenitors and
cultured in perfusion bioreactor for 1 week in the presence of
cardiogenic medium. As a result, a 3D cardiac proto-tissue com-
posed of densely packed cardiomyocyte-like cells intertwined
with vessel-like structures was obtained. Although being promis-
ing in terms of cell colonization and survival, these co-culture
conditions did not yield the formation of functional contractile
and vascular structures. Thus additional experiments will be nec-
essary to provide cells with other cues in vitro to complete the
organization of a proper vascularized cardiac tissue.
Nonetheless, irrespective of the stem cell subsets used, the
procedure here described provides a novel platform for the
preparation of complex 3D vascularized bio-constructs to be used
for in vitro studies aiming at the understanding of stem cell behav-
ior in a more physiological context. Pre-clinical animal studies
addressing the long-term in vivo survival and the relevance of the
constructs will be necessary before this technique may represent a
suitable platform for future clinical applications.
ACKNOWLEDGMENTS
The present work was supported by the Japan Society for the
Promotion of Science (JSPS) through the “Funding Program
for World-Leading Innovative R&D on Science and Technology
(FIRST Program)” and the World Premier International (WPI)
Research Center Initiative. Stefania Pagliari was supported
by JSPS fellowship; Marie-Josè Goumans was supported by
Netherlands Institute for Regenerative Medicine (NIRM) and
Giancarlo Forte by the European Regional Development Fund—
Project FNUSA-ICRC (No. CZ.1.05/1.1.00/02.0123).
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found online
at: http://www.frontiersin.org/journal/10.3389/fphys.2014.
00210/abstract
REFERENCES
Abramoff, M. D., Magalhaes, P. J., and Ram, S. J. (2004). Image processing with
ImageJ. Biophoton. Int. 11, 36–42.
Akhyari, P., Fedak, P. W., Weisel, R. D., Lee, T. Y., Verma, S., Mickle, D. A.,
et al. (2002). Mechanical stretch regimen enhances the formation of bio-
engineered autologous cardiac muscle grafts. Circulation 106, I137–I142. doi:
10.1161/01.cir.0000032893.55215.fc
Bai, K., Huang, Y., Jia, X., Fan, Y., and Wang, W. (2010). Endothelium
oriented differentiation of bone marrow mesenchymal stem cells under
chemical and mechanical stimulations. J. Biomech. 43, 1176–1181. doi:
10.1016/j.jbiomech.2009.11.030
Beltrami, A. P., Barlucchi, L., Torella, D., Baker, M., Limana, F., Chimenti,
S., et al. (2003). Adult cardiac stem cells are multipotent and support
myocardial regeneration. Cell 114, 763–776. doi: 10.1016/S0092-8674(03)
00687-1
Bolli, R., Chugh, A. R., D’Amario, D., Loughran, J. H., Stoddard, M. F., Ikram,
S., et al. (2011). Cardiac stem cells in patients with ischaemic cardiomyopathy
(SCIPIO): initial results of a randomised phase 1 trial. Lancet 378, 1847–1857.
doi: 10.1016/S0140-6736(11)61590-0
Boschetti, F., Raimondi, M. T., Migliavacca, F., and Dubini, G. (2006).
Prediction of the micro-fluid dynamic environment imposed to three-
dimensional engineered cell systems in bioreactors. J. Biomech. 39, 418–425. doi:
10.1016/j.jbiomech.2004.12.022
Brannon-Peppas, L., and Peppas, N. A. (1990). Dynamic and equilibrium swelling
behaviour of pH-sensitive hydrogels containing 2-hydroxyethyl methacrylate.
Biomaterials 11, 635–644.
Bround, M. J., Asghari, P., Wambolt, R. B., Bohunek, L., Smits, C., Philit, M., et al.
(2012). Cardiac ryanodine receptors control heart rate and rhythmicity in adult
mice. Cardiovasc. Res. 96, 372–380. doi: 10.1093/cvr/cvs260
Burdick, J. A., and Vunjak-Novakovic, G. (2009). Engineered microenvironments
for controlled stem cell differentiation. Tissue Eng. Part A 15, 205–219. doi:
10.1089/ten.tea.2008.0131
Caspi, O., Lesman, A., Basevitch, Y., Gepstein, A., Arbel, G., Habib, I. H.,
et al. (2007). Tissue engineering of vascularized cardiac muscle from human
Frontiers in Physiology | Striated Muscle Physiology June 2014 | Volume 5 | Article 210 | 10
Pagliari et al. Vascularized cardiac constructs
embryonic stem cells. Circ. Res. 100, 263–272. doi: 10.1161/01.RES.0000257776.
05673.ff
Chiu, L. L., and Radisic, M. (2010). Scaffolds with covalently immobilized VEGF
and angiopoietin-1 for vascularization of engineered tissues. Biomaterials 31,
226–241. doi: 10.1016/j.biomaterials.2009.09.039
Cimetta, E., Flaibani, M., Mella, M., Serena, E., Boldrin, L., De Coppi, P., et al.
(2007). Enhancement of viability of muscle precursor cells on 3D scaffold in a
perfusion bioreactor. Int. J. Artif. Organs 30, 415–428.
Cipolleschi, M. G., Dello Sbarba, P., and Olivotto, M. (1993). The role of hypoxia
in the maintenance of hematopoietic stem cells. Blood 82, 2031–2037.
Dreesmann, L., Ahlers, M., and Schlosshauera, B. (2007). The pro-angiogenic char-
acteristics of a cross-linked gelatin matrix. Biomaterials 28, 5536–5543. doi:
10.1016/j.biomaterials.2007.08.040
Dubois, C., Liu, X., Claus, P., Marsboom, G., Pokreisz, P., Vandenwijngaert, S.,
et al. (2010). Differential effects of progenitor cell populations on left ventricu-
lar remodeling and myocardial neovascularization after myocardial infarction.
J. Am. Coll. Cardiol. 55, 2232–2243. doi: 10.1016/j.jacc.2009.10.081
Dvir, T., Kedem, A., Ruvinov, E., Levy, O., Freeman, I., Landa, N., et al.
(2009). Prevascularization of cardiac patch on the omentum improves its
therapeutic outcome. Proc. Natl. Acad. Sci. U.S.A. 106, 14990–14995. doi:
10.1073/pnas.0812242106
Engler, A. J., Rehfeldt, F., Sen, S., and Discher, D. E. (2007). Microtissue elasticity:
measurements by atomic force microscopy and its influence on cell differentia-
tion. Methods Cell Biol. 83, 521–545. doi: 10.1016/S0091-679X(07)83022-6
Engler, A. J., Sen, S., Sweeney, H. L., and Discher, D. E. (2006). Matrix
elasticity directs stem cell lineage specification. Cell 126, 677–689. doi:
10.1016/j.cell.2006.06.044
Forte, G., Pagliari, S., Pagliari, F., Ebara, M., Di Nardo, P., and Aoyagi, T. (2013).
Towards the generation of patient-specific patches for cardiac repair. Stem Cell
Rev. 9, 313–325. doi: 10.1007/s12015-011-9325-8
Forte, G., Pietronave, S., Nardone, G., Zamperone, A., Magnani, E., Pagliari,
S., et al. (2011). Human cardiac progenitor cell grafts as unrestricted source
of super-numerary cardiac cells in healthy murine hearts. Stem Cells 29,
2051–2061. doi: 10.1002/stem.763
Gaetani, R., Doevendans, P. A., Metz, C. H., Alblas, J., Messina, E., Giacomello,
A., et al. (2012). Cardiac tissue engineering using tissue printing technol-
ogy and human cardiac progenitor cells. Biomaterials 33, 1782–1790. doi:
10.1016/j.biomaterials.2011.11.003
Gnecchi, M., He, H., Liang, O. D., Melo, L. G., Morello, F., Mu, H., et al.
(2005). Paracrine action accounts for marked protection of ischemic heart
by Akt-modified mesenchymal stem cells. Nat. Med. 11, 367–368. doi:
10.1038/nm0405-367
Gnecchi, M., Zhang, Z., Ni, A., and Dzau, V. J. (2008). Paracrine mechanisms
in adult stem cell signaling and therapy. Circ. Res. 103, 1204–1219. doi:
10.1161/CIRCRESAHA.108.176826
Goumans, M. J., de Boer, T. P., Smits, A. M., van Laake, L. W., van Vliet, P., Metz,
C. H., et al. (2007). TGF-beta1 induces efficient differentiation of human car-
diomyocyte progenitor cells into functional cardiomyocytes in vitro. Stem Cell
Res. 1, 138–149. doi: 10.1016/j.scr.2008.02.003
Haraguchi, Y., Shimizu, T., Yamato, M., Kikuchi, A., and Okano, T.
(2006). Electrical coupling of cardiomyocyte sheets occurs rapidly via
functional gap junction formation. Biomaterials 27, 4765–4774. doi:
10.1016/j.biomaterials.2006.04.034
Heng, B. C., Haider, H. Kh., Sim, E. K., Cao, T., and Ng, S. C. (2004).
Strategies for directing the differentiation of stem cells into the cardiomyo-
genic lineage in vitro. Cardiovasc. Res. 62, 34–42. doi: 10.1016/j.cardiores.2003.
12.022
Jazayeri, M., Allameh, A., Soleimani, M., Jazayeri, S. H., Piryaei, A., and
Kazemnejad, S. (2008). Molecular and ultrastructural characterization of
endothelial cells differentiated from human bone marrow mesenchymal stem
cells. Cell Biol. Int. 32, 1183–1192. doi: 10.1016/j.cellbi.2008.07.020
Kang, K. T., Coggins, M., Xiao, C., Rosenzweig, A., and Bischoff, J. (2013). Human
vasculogenic cells form functional blood vessels and mitigate adverse remod-
eling after ischemia reperfusion injury in rats. Angiogenesis 16, 773–784. doi:
10.1007/s10456-013-9354-9
Lalu, M. M., McIntyre, L., Pugliese, C., Fergusson, D., Winston, B. W., Marshall,
J. C., et al. (2012). Safety of cell therapy with mesenchymal stromal cells
(SafeCell): a systematic review and meta-analysis of clinical trials. PLoS ONE
7:e47559. doi: 10.1371/journal.pone.0047559
Levenberg, S., Rouwkema, J., Macdonald, M., Garfein, E. S., Kohane, D. S.,
Darland, D. C., et al. (2005). Engineering vascularized skeletal muscle tissue.
Nat. Biotechnol. 23, 879–884. doi: 10.1038/nbt1109
Lian, F., Xue, S., Gu, P., and Zhu, H. S. (2008). The long-term effect of
autologous endothelial progenitor cells from peripheral blood implantation
on infarcted myocardial contractile force. J. Int. Med. Res. 36, 40–46. doi:
10.1177/147323000803600106
Lien, S. M., Ko, L. Y., and Huang, T. J. (2009). Effect of pore size and ECM secretion
and cell growth in gelatin scaffold for articular cartilage tissue engineering. Acta
Biomater. 5, 670–679. doi: 10.1016/j.actbio.2008.09.020
Loffredo, F. S., Steinhauser, M. L., Gannon, J., and Lee, R. T. (2011). Bone marrow-
derived cell therapy stimulates endogenous cardiomyocyte progenitors and
promotes cardiac repair. Cell Stem Cell 8, 389–398. doi: 10.1016/j.stem.2011.
02.002
Lovett, M., Lee, K., Edwards, A., and Kaplan, D. L. (2009). Vascularization
strategies for tissue engineering. Tissue Eng. Part B Rev. 15, 353–370. doi:
10.1089/ten.TEB.2009.0085
Lozito, T. P., Kuo, C. K., Taboas, J. M., and Tuan, R. S. (2009). Humanmesenchymal
stem cells express vascular cell phenotypes upon interaction with endothelial
cell matrix. J. Cell. Biochem. 107, 714–722. doi: 10.1002/jcb.22167
Maidhof, R., Tandon, N., Lee, E. J., Luo, J., Duan, Y., Yeager, K., et al. (2012).
Biomimetic perfusion and electrical stimulation applied in concert improved
the assembly of engineered cardiac tissue. J. Tissue Eng. Regen. Med. 6, e12–e23.
doi: 10.1002/term.525
Makkar, R. R., Smith, R. R., Cheng, K., Malliaras, K., Thomson, L. E., Berman, D.,
et al. (2012). Intracoronary cardiosphere-derived cells for heart regeneration
after myocardial infarction (CADUCEUS): a prospective, randomised phase 1
trial. Lancet 379, 895–904. doi: 10.1016/S0140-6736(12)60195-0
Martucci, J. F., Ruseckaite, R. A., and Vàzquez, A. (2006). Creep of glutaraldehyde-
crosslinked gelatin films. Mater. Sci. Eng. A 435–436, 681–686. doi:
10.1016/j.msea.2006.07.097
Matsuura, K., Wada, M., Konishi, K., Sato, M., Iwamoto, U., Sato, Y., et al. (2012).
Fabrication of mouse embryonic stem cell-derived layered cardiac cell sheets
using a bioreactor culture system. PLoS ONE 7:e52176. doi: 10.1371/jour-
nal.pone.0052176
Mazzei, D., Guzzardi, M. A., Giusti, S., and Ahluwalia, A. (2010). A low shear stress
modular bioreactor for connected cell culture under high flow rates. Biotechnol.
Bioeng. 106, 127–137. doi: 10.1002/bit.22671
Mehta, A., and Shim, W. (2013). Cardiac stem cell therapy: stemness or commit-
ment? Cell Transplant. 22, 1–14. doi: 10.3727/096368912X653282
Menasche, P. (2011). Cardiac cell therapy: lessons from clinical trials. J. Mol. Cell.
Cardiol. 50, 258–265. doi: 10.1016/j.yjmcc.2010.06.010
Meyer, G. P., Wollert, K. C., Lotz, J., Pirr, J., Rager, U., Lippolt, P., et al. (2009).
Intracoronary bone marrow cell transfer after myocardial infarction: 5-year
follow-up from the randomized-controlled BOOST trial. Eur. Heart J. 30,
2978–2984. doi: 10.1093/eurheartj/ehp374
Mosqueira, D., Pagliari, S., Uto, K., Ebara, M., Romanazzo, S., Escobedo-Lucea, C.,
et al. (2014). Hippo pathway effectors control cardiac progenitor cell fate by
acting as dynamic sensors of substrate mechanics and nanostructure. ACS Nano
8, 2033–2047. doi: 10.1021/nn4058984
Muraglia, A., Cancedda, R., and Quarto, R. (2000). Clonal mesenchymal progeni-
tors from human bone marrow differentiate in vitro according to a hierarchical
model. J. Cell Sci. 113, 1161–1166.
Mwangi, J. W., and Ofner, C. M. 3rd (2004). Crosslinked gelatin matrices: release
of a random coil macromolecular solute. Int. J. Pharm. 278, 319–327. doi:
10.1016/j.ijpharm.2004.03.024
Oswald, J., Boxberger, S., Jorgensen, B., Feldmann, S., Ehninger, G., Bornhauser,
M., et al. (2004). Mesenchymal stem cells can be differentiated into endothelial
cells in vitro. Stem Cells 22, 377–384. doi: 10.1634/stemcells.22-3-377
Pagliari, S., Romanazzo, S., Mosqueira, D., Pinto-do-Ó, P., Aoyagi, T., and
Forte, G. (2013). Adult stem cells and biocompatible scaffolds as powerful
drug delivery tools for cardiac repair. Curr. Med. Chem. 20, 3429–3447. doi:
10.2174/09298673113209990032
Pagliari, S., Vilela-Silva, A. C., Forte, G., Pagliari, F., Mandoli, C., Vozzi, G., et al.
(2011). Cooperation of biological and mechanical signals in cardiac progenitor
cell differentiation. Adv. Mater. 23, 514–518. doi: 10.1002/adma.201003479
Pampaloni, F., Reynaud, E. G., and, Stelzer, E. H. (2007). The third dimension
bridges between cell culture and live tissue. Nat. Rev. Mol. Cell Biol. 8, 839–845.
doi: 10.1038/nrm2236
www.frontiersin.org June 2014 | Volume 5 | Article 210 | 11
Pagliari et al. Vascularized cardiac constructs
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D.,
et al. (1999). Multilineage potential of adult human mesenchymal stem cells.
Science 284,143–147. doi: 10.1126/science.284.5411.143
Portalska, K. J., Leferink, A., Groen, N., Fernandes, H., Moroni, L., van Blitterswijk,
C., et al. (2012). Endothelial differentiation of mesenchymal stromal cells. PLoS
ONE 7:e46842. doi: 10.1371/journal.pone.0046842
Sakaguchi, K., Shimizu, T., Haraguchi, S., Sekine, H., Yamato, M., Umezu, M., et al.
(2013). In vitro engineering of vascularized tissue surrogates. Sci. Rep. 3:1316.
doi: 10.1038/srep01316
Sakai, T., Li, R. K., Weisel, R. D., Mickle, D. A., Kim, E. T., Jia, Z. Q., et al.
(2001). The fate of a tissue-engineered cardiac graft in the right ventricu-
lar outflow tract of the rat. J. Thorac. Cardiovasc. Surg. 121, 932–942. doi:
10.1067/mtc.2001.113600
Sato, K.,Wu, T., Laham, R. J., Johnson, R. B., Douglas, P., Li, J., et al. (2001). Efficacy
of intracoronary or intravenous VEGF165 in a pig model of chronic myocar-
dial ischemia. J. Am. Coll. Cardiol. 37, 616–623. doi: 10.1016/S0735-1097(00)
01144-X
Segers, V. F. M., and Lee, R. T. (2011). Biomaterials to enhance stem cell function
in the heart. Circ. Res. 109, 910–922. doi: 10.1161/CIRCRESAHA.111.249052
Sekine, H., Shimizu, T., Sakaguchi, K., Dobashi, I., Wada, M., Yamato, M.,
et al. (2013). In vitro fabrication of functional three-dimensional tis-
sues with perfusable blood vessels. Nat. Commun. 4:1399. doi: 10.1038/
ncomms2406
Simons, M., and Ware, J. A. (2003). Therapeutic angiogenesis in cardiovascular
disease. Nat. Rev. Drug Discov. 2, 863–871. doi: 10.1038/nrd1226
Simón-Yarza, T., Formiga, F. R., Tamayo, E., Pelacho, B., Prosper, F., and Blanco-
Prieto, M. J. (2012). Vascular endothelial growth factor-delivery systems for
cardiac repair: an overview. Theranostics 2, 541–552. doi: 10.7150/thno.3682
Singh, S., Wu, B. M., and Dunn, J. C. (2012). Delivery of VEGF using collagen-
coated polycaprolactone scaffolds stimulates angiogenesis. J. Biomed.Mater. Res.
100, 720–727. doi: 10.1002/jbm.a.34010
Smits, A. M., van Laake, L. W., den Ouden, K., Schreurs, C., Szuhai, K., van Echteld,
C. J., et al. (2009a). Human cardiomyocyte progenitor cell transplantation pre-
serves long-term function of the infarcted mouse myocardium. Cardiovasc. Res.
83, 527–535. doi: 10.1093/cvr/cvp146
Smits, A. M., van Vliet, P., Metz, C. H., Korfage, T., Sluijter, J. P., Doevendans,
P. A., et al. (2009b). Human cardiomyocyte progenitor cells differenti-
ate into functional mature cardiomyocytes: an in vitro model for studying
human cardiac physiology and pathophysiology. Nat. Protoc. 4, 232–243. doi:
10.1038/nprot.2008.229
Spinelli, A., Vinci, B., Tirella, A., Matteucci, M., Gargani, L., Ahluwalia, A., et al.
(2012). Realization of a poro-elastic ultrasound replica of pulmonary tissue.
Biomatter 2, 37–42. doi: 10.4161/biom.19835
Terrovitis, J. V., Smith, R. R., and Marbán, E. (2010). Assessment and optimization
of cell engraftment after transplantation into the heart Circ. Res. 106, 479–494.
doi: 10.1161/CIRCRESAHA.109.208991
Thomas, M., and Augustin, H. G. (2009). The role of the Angiopoietins in vascular
morphogenesis. Angiogenesis 12, 125–137. doi: 10.1007/s10456-009-9147-3
Urbich, C., Heeschen, C., Aicher, A., Sasaki, K., Bruhl, T., Farhadi, M. R., et al.
(2005). Cathepsin L is required for endothelial progenitor cell-induced neovas-
cularization. Nat. Med. 11, 206–213. doi: 10.1038/nm1182
Varum, S., Rodrigues, A. S., Moura, M. B., Momcilovic, O., Easley, C. A. 4th,
Ramalho-Santos, J., et al. (2011). Energy metabolism in human pluripotent
stem cells and their differentiated counterparts. PLoS ONE 6:e20914. doi:
10.1371/journal.pone.0020914
Vozzi, F., Mazzei, D., Vinci, B., Vozzi, G., Sbrana, T., Ricotti, L., et al. (2011). A
flexible bioreactor system for constructing in vitro tissue and organ models.
Biotechnol. Bioeng. 108, 2129–2140. doi: 10.1002/bit.23164
Wang, D. M., and Tarbell, J. M. (1995). Modeling interstitial flow in an artery wall
allows estimation of wall shear stress on smooth muscle cells. J. Biomech. Eng.
117, 358–366.
Wöhrle, J., Merkle, N., Mailänder, V., Nusser, T., Schauwecker, P., von Scheidt, F.,
et al. (2010). Results of intracoronary stem cell therapy after acute myocardial
infarction. Am. J. Cardiol. 105, 804–812. doi: 10.1016/j.amjcard.2009.10.060
Wu, S. C., Chang, W. H., Dong, C. G., Chen, K. Y., Chen, Y. S., and Yao, C. H.
(2011). Cell adhesion and proliferation enhancement by gelatin nanofiber scaf-
folds. J. Bioact. Compat. Polym. 26, 565–577. doi: 10.1177/0883911511423563
Xing, Q., Yates, K., Vogt, C., Qian, Z., Frost, M. C., and Zhao, F. (2014). Increasing
mechanical strength of gelatin hydrogels by divalent metal ion removal. Sci. Rep.
4:4706. doi: 10.1038/srep04706
Zimmermann, W. H., Melnychenko, I., Wasmeier, G., Didié, M., Naito, H.,
Nixdorff, U., et al. (2006). Engineered heart tissue grafts improve systolic
and diastolic function in infarcted rat hearts. Nat. Med. 12, 452–458. doi:
10.1038/nm1394
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be
construed as a potential conflict of interest.
Received: 21 March 2014; accepted: 15 May 2014; published online: 03 June 2014.
Citation: Pagliari S, Tirella A, Ahluwalia A, Duim S, Goumans M-J, Aoyagi T and
Forte G (2014) A multistep procedure to prepare pre-vascularized cardiac tissue con-
structs using adult stem sells, dynamic cell cultures, and porous scaffolds. Front.
Physiol. 5:210. doi: 10.3389/fphys.2014.00210
This article was submitted to Striated Muscle Physiology, a section of the journal
Frontiers in Physiology.
Copyright © 2014 Pagliari, Tirella, Ahluwalia, Duim, Goumans, Aoyagi and Forte.
This is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums is
permitted, provided the original author(s) or licensor are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice. No
use, distribution or reproduction is permitted which does not comply with these terms.
Frontiers in Physiology | Striated Muscle Physiology June 2014 | Volume 5 | Article 210 | 12
